Caitlin Zulla - 11 Dec 2025 Form 3 Insider Report for Lumexa Imaging Holdings, Inc. (LMRI)

Role
Chief Executive Officer, Director
Signature
/s/ Julie Szeker, attorney-in-fact
Issuer symbol
LMRI
Transactions as of
11 Dec 2025
Net transactions value
$0
Form type
3
Filing time
11 Dec 2025, 19:56:23 UTC
Previous filing
23 Jun 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zulla Caitlin Chief Executive Officer, Director 4200 SIX FORKS ROAD, SUITE 1000, RALEIGH /s/ Julie Szeker, attorney-in-fact 11 Dec 2025 0002031509

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LMRI Common Units of Holdings LLC 11 Dec 2025 Common Stock 14,948 Direct F1
holding LMRI Stock Option (right to buy) 11 Dec 2025 Common Stock 833,333 $18.50 Direct F2
holding LMRI Stock Option (right to buy) 11 Dec 2025 Common Stock 833,333 $18.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common units ("Common Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. Each nine Common Units represent the right to acquire one share of the Issuer's common stock ("Common Stock") held by Holdings LLC. After the closing of the Issuer's initial public offering ("IPO"), Holdings LLC may distribute all or a portion of the shares of the Common Stock it holds to its remaining equity holders on a pro rata basis, not earlier than the expiration of a 180-day lock-up period (a "Distribution"). Accordingly, the shares of Common Stock reported on this row represent shares of Common Stock that the Reporting Person is entitled to receive in connection with a Distribution in exchange for their Common Units.
F2 The shares of Common Stock subject to the stock option vest annually in five substantially equal installments from the vesting commencement date of January 1, 2025, subject to the Reporting Person's continued service with the Issuer.
F3 The shares of Common Stock subject to the stock option will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney